LIA
HALO icon

LS Investment Advisors’s Halozyme HALO Stock Holding History

LS Investment Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,885
Closed -$370K – 400
2021
Q1 		$370K Sell
8,885
-1,662
-16% -$75.9K 0.02% 480
2020
Q4 		$450K Buy
+10,547
New +$379K 0.02% 460

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LS Investment Advisors's HALO Position: Q2 2021 in Review

LS Investment Advisors sold out of Halozyme (HALO) in Q2 2021, closing a stake of 8,885 shares — an estimated $370K sold.

LS Investment Advisors first reported a position in HALO in Q4 2020 and held it in 2 quarters. The position peaked at $450K in Q4 2020. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

  • LS Investment Advisors reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 8,885 Halozyme shares in Q2 2021, an estimated $370K.
  • LS Investment Advisors first reported a position in Halozyme in Q4 2020 and held it in 2 quarters.
  • LS Investment Advisors's Halozyme position peaked at $450K in Q4 2020.
  • 313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.